Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-15025 |
Trade Name | |
Synonyms | BGB15025|BGB 15025 |
Drug Descriptions |
BGB-15025 is a small molecule inhibitor of MAP4K1 (HPK1,MEKKK1), which may prevent immunosuppression in the tumor microenvironment and activate anti-tumor immune response (NCI Thesaurus). |
DrugClasses | MAP4K1 Inhibitor 7 |
CAS Registry Number | NA |
NCIT ID | C178833 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-15025 | BGB-15025 | 0 | 1 |
BGB-15025 + Tislelizumab | BGB-15025 Tislelizumab | 0 | 1 |